Since the prognostic value of SLC4A4 was mainly evaluated in COAD (Chen et al., 2020; Gao and Yang, 2020; Yang et al., 2020; Yang W. et al., 2022), this in silico evaluation could represent the starting point for the validation of its significance in other tumors. Here, SLC4A4 is linked to colon adenocarcinoma.